News
Fewer than 1 in 3 children with hepatitis C (HCV) see a clinician for care, and fewer than 1 in 8 receive treatment.
A mother gives her baby immunity even before birth. Vaccines during pregnancy protect both, boosting the baby's defense ...
Explore seven biotech companies advancing clinical drugs in the race for regulatory approval to revolutionize hepatitis B ...
Gain valuable insights into novel therapies, ongoing clinical trials, and future innovations shaping the treatment of ...
Fatigue and yellowing eyes may signal hepatitis, a serious liver issue. Learn the symptoms, causes, prevention, and available ...
Viral hepatitis was the most common cause of infectious disease mortality worldwide after tuberculosis in 2024, according to ...
Three doses of COVID-19 mRNA vaccination induce long-lasting antibody and memory B-cell responses, according to a study of 113 health care workers in Catalonia who were followed for three years.
Credit: RealPeopleGroup via Getty Images. UK biotech Epsilogen has acquired US-based antibody developer TigaTx in a deal that collates work from the two companies’ alternative antibody isotopes for ...
State Key Laboratory of Medical Proteomics, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, Dalian 116023, China University of Chinese Academy of Sciences, Beijing 101408, China ...
According to data released by the Kerala Department of Health, between March 11 and March 31 alone, Ernakulam district recorded 110 Hepatitis A cases. The situation has become increasingly ...
Over 300 cases of hepatitis A have been reported so far ... has resulted in a growing number of people without protective antibodies who are highly susceptible to infection. This mainly concerns ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results